Discovery and Characterization of Oligonucleotide Therapeutics

DATE

December 1, 2022

TIME

8:00 a.m. PST / 11:00 a.m. EST / 16:00 GMT / 17:00 CET - Duration: 60 Minutes

Overview

Recent years have seen a huge surge of interest in oligonucleotide therapeutics, fueled by major advances in our understanding of how to make such molecules stable, selective, and efficient as drug modalities. The field is now diverse in terms of therapeutic areas being addressed, biological processes being manipulated and delivery technologies employed. This webinar will present recent developments in oligonucleotide chemistry, biology, and DMPK.

Our speaker panel of experts are involved in providing state of the art technical support to the discovery stages of an oligonucleotide therapeutic program. They will review the synthesis and modification of oligonucleotides, design and execution of suitable in vitro and in vivo assays, and methods for determining pharmacokinetic parameters. Finally, our expert panel will be available for a question-and-answer session.

Key Learning Objectives:

Examine the synthesis and modification of oligonucleotides
Explore methods for determining pharmacokinetic parameters
Hear about state-of-the-art discovery strategies

Who Should Attend:

Professionals working in the following areas of oligonucleotide science: Drug Discovery, Preclinical, RNA Biology/Discovery, Novel Therapeutic Modalities

Brought to you by:

Speakers

Dave Madge
Vice President,
WuXi AppTec

Qiong Zhou
Executive Director, Discovery Biology,
WuXi AppTec

Jun Zhou
Senior Principal Scientist, Associate Director,
WuXi AppTec

Nan Zhao
Principle Scientist III, DMPK Service Department,
WuXi AppTec

Catherine Dold
Health & Environment Writer,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

Address 1

City

State*

Zip / Post Code

Country*

Business Phone

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

View On Demand Webinars